Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: Correlation with clinicopathological criteria

Author：              

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.3, 2013-01, pp. : 1043-1052

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

By Lai Yuen-Liang  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1064-1069

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA mutations in breast cancer are associated with poor outcome

By Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 91-95

Springer Publishing Company

Access to resources Recommend Favorite

Mutations of the PIK3CA gene in ovarian and breast cancer

By Bellacosa Alfonso  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 223-225

Informa Healthcare

Access to resources Recommend Favorite

BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis

By                        

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 141-145

Spandidos Publications

Access to resources Recommend Favorite

A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: Correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features

By                      

Oncology Reports, Vol. 30, Iss. 2, 2013-01 ,pp. : 623-636

Spandidos Publications

Access to resources Recommend Favorite